FDA rolls out new draft guidance on advanced manufacturing technews2023-12-12T18:31:01+00:00December 12th, 2023|Endpoints News|
Bispecifics continue impressive efficacy streak, but companies look to reduce side effects: #ASH23news2023-12-12T18:14:54+00:00December 12th, 2023|Endpoints News|
MarketingRx roundup: AbbVie, Sanofi and Regeneron lead pharma ad spend; BMS launches new equity grantsnews2023-12-12T17:43:25+00:00December 12th, 2023|Endpoints News|
J&J and Genmab tout first-line injectable Darzalex for multiple myeloma at ASHnews2023-12-12T17:00:28+00:00December 12th, 2023|Endpoints News|
Resilience plans to expand Ohio facility with 440 new jobs over three yearsnews2023-12-12T16:22:36+00:00December 12th, 2023|Endpoints News|
Almirall partners with etherna; Daiichi’s RNA deal with Depixus; SQZ founder’s startup emerges from stealthnews2023-12-12T16:20:34+00:00December 12th, 2023|Endpoints News|
Moderna’s chief commercial officer out as company reorganizesnews2023-12-12T16:11:43+00:00December 12th, 2023|Endpoints News|
Icosavax buyout caps AstraZeneca’s long search for a vaccine platformnews2023-12-12T16:11:20+00:00December 12th, 2023|Endpoints News|
After groundbreaking year for RSV approvals, GSK looks to model pediatric success for adult vaccinesnews2023-12-12T14:36:50+00:00December 12th, 2023|Endpoints News|
FDA sets late 2024 decision deadline for Pfizer’s ‘pan-hemophilia’ drug: #ASH23news2023-12-12T13:14:01+00:00December 12th, 2023|Endpoints News|
